Biopharmaceutical manufacturing industry inbound supply chain strategic framework
The Covid 19 pandemic not only highlighted the importance of the inbound supply chain, but also potentially some of the long-standing frailties in the system. If we are to adjust to the new normal as we move from a 'Pandemic to Endemic' situation, the industry recognizes it needs to take ownership of the development of the in-bound supply chain.
This framework is intended to guide our collaborative approach to problem solving some of the most important supply chain issues for the industry over the next 2–5-year horizon - raising standards globally. The framework identifies the key five strategic objectives that will help drive operational excellence and improvements needed to address these issue
Attached Files
File | |
---|---|
Biopharmaceutical manufacturing industry inbound supply chain strategic framework November 2021.pdf |

- Version
- Download 9
- File Size 412.46 KB
- File Count 1
- Create Date 3rd November 2021
- DOI
- Last Updated